Jupiter Asset Management Ltd. trimmed its holdings in shares of Chemed Corporation (NYSE:CHE – Free Report) by 10.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 61,974 shares of the company’s stock after selling 7,589 shares during the period. Jupiter Asset Management Ltd.’s holdings in Chemed were worth $27,748,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also made changes to their positions in the business. Syon Capital LLC acquired a new stake in shares of Chemed during the 3rd quarter worth about $212,000. Maridea Wealth Management LLC acquired a new position in Chemed in the third quarter valued at approximately $527,000. GSA Capital Partners LLP purchased a new position in Chemed in the third quarter valued at approximately $273,000. JPMorgan Chase & Co. raised its holdings in Chemed by 122.7% during the third quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock worth $223,856,000 after purchasing an additional 275,423 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D raised its holdings in Chemed by 9.3% during the third quarter. State of New Jersey Common Pension Fund D now owns 5,186 shares of the company’s stock worth $2,322,000 after purchasing an additional 441 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Chemed
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the transaction, the chief executive officer owned 94,197 shares of the company’s stock, valued at $41,215,897.35. This trade represents a 2.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 3.29% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Report on Chemed
Chemed Price Performance
CHE stock opened at $475.35 on Friday. The company has a market cap of $6.73 billion, a price-to-earnings ratio of 25.14, a price-to-earnings-growth ratio of 2.30 and a beta of 0.44. The company has a fifty day moving average price of $444.77 and a 200 day moving average price of $443.47. Chemed Corporation has a 12 month low of $408.42 and a 12 month high of $623.60.
Chemed Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Monday, February 23rd will be paid a dividend of $0.60 per share. The ex-dividend date is Monday, February 23rd. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed’s dividend payout ratio is 12.69%.
About Chemed
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
See Also
- Five stocks we like better than Chemed
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
